Oventus Medical Ltd

ASX:OVN ISIN:AU000000OVN3

Oventus Medical Ltd (ASX:OVN) is a Brisbane based medical device company that is commercialising a unique treatment platform for the treatment of sleep apnoea and snoring. Unlike other oral appliances or CPAP interfaces, the Oventus devices have a unique and patented airway within the treatment platform that allows air to flow to the back of the mouth unobstructed while maintaining an oral seal and stable jaw position, bypassing multiple obstructions from the nose, soft palate and tongue, reducing airway collapsibility and managing mouth breathing while maintain a stable airway with or without nasal CPAP. They are particularly designed for the many people that have nasal obstructions and consequently tend to mainly breathe through their mouth. While it may seem counterintuitive, this technology actually manages mouth breathing by converting it to device breathing and normalising ventilation. The O2Vent(TM) is designed to allow nasal breathing when the nose is unobstructed, but when obstruction is present, breathing is supplemented via the airways in the appliance.

For more information on Oventus' Sleep Treatment Platform, please visit http://www.oventus.com

       

Latest Headlines

Oventus Medical Ltd (ASX:OVN) O2Vent Optima Launch in Canada

🕔2/4/2019 10:59:31 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent(R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea and snoring. The device launch in Canada follows the successful completion of a controlled market release, with early results demonstrating strong patient acceptance.

Read Full Article

Oventus Medical Ltd (ASX:OVN) New Nylon O2Vent Optima Oral Device Launched in Australia

🕔1/8/2019 10:36:18 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the launch of the O2Vent(R) Optima device in Australia, an important addition to the Company's sleep treatment platform.

Read Full Article

Oventus Medical Ltd (ASX:OVN) 2018 AGM Presentation

🕔11/16/2018 12:12:19 PM

Oventus Medical Ltd (ASX:OVN) provides the Company's 2018 AGM Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) New Clinical Trial Data Demonstrates Sleep Treatment Platform Delivers Significantly Improved Treatment Outcomes for OSA Sufferers

🕔10/18/2018 10:24:42 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce that new clinical data from four separate studies on its Sleep Treatment Platform will be presented at Sleep DownUnder, the 30th annual meeting of sleep specialists, taking place in Brisbane between 17th -20th October.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Appoints Medical Technology Advisory Board to Guide Commercialisation of Sleep Treatment Platform

🕔9/5/2018 4:40:07 PM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the appointment of a Medical Technology Advisory Board of international sleep experts to help guide the development and commercialisation of the Company's Sleep Treatment Platform.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Quarterly Business Review - Q4 FY2018

🕔7/24/2018 8:42:47 AM

Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 30 June 2018 (Q4 FY2018) and is pleased to provide a review of progress made during the quarter.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Newsletter

🕔6/20/2018 10:17:57 AM

Oventus Medical Ltd (ASX:OVN) is pleased to provide a copy of its latest newsletter for investors.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Innovators in Sleep Apnoea Treatment Presentation for Thorney Investment Forum

🕔5/31/2018 11:29:38 AM

Oventus Medical Ltd (ASX:OVN) is pleased to attach a copy of the presentation that Founder and Clinical Director, Dr Chris Hart will deliver to investors this morning at the Thorney Sydney Investment Forum.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Data Shows O2Vent with New Valve Treats 75% of Patients

🕔5/29/2018 2:09:34 PM

Oventus Medical Ltd (ASX:OVN) is pleased to announce positive interim data being presented today in a lecture at Macquarie University on a group of hard-to-treat obstructive sleep apnoea patients, who were studied in a sub-group as part of the ongoing "NeuRA Sydney study".

Read Full Article

Oventus Medical Ltd (ASX:OVN) Airway Technology Achieves Positive Clinical Trial

🕔5/22/2018 10:21:38 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the results of the OVEN-003 clinical trial study being conducted in Brisbane by the company, a randomised controlled clinical trial examining the treatment outcomes of oral appliance therapy with and without 'Oventus Airway Technology'.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Quarterly Business Review

🕔4/23/2018 9:29:36 AM

Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 31 March 2018 (Q3 FY2018) and is pleased to provide a review of progress made during the quarter.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Presentation

🕔9/27/2017 8:23:33 AM

Oventus Medical Ltd (ASX:OVN) provide the latest Investor Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Audited Financial Statements and Appendix 4E

🕔8/31/2017 1:27:22 PM

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to release its Appendix 4E with its full year audited general purpose financial report for the period ending 30 June 2017.

Read Full Article

FINANCE VIDEO: Oventus Medical Ltd (ASX:OVN) Financial News Network Interview

🕔8/24/2017 10:00:45 AM

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Appendix 4C - Quarterly Cash Flow Report

🕔7/31/2017 9:45:46 AM

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has today released its Appendix 4C - Quarterly cash flow report for the period ended 30 June 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Extension of Share Purchase Plan

🕔7/14/2017 11:26:52 AM

Oventus Medical Limited (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. Oventus wishes to advise that the closing date for the SPP will be extended from Wednesday 19 July 2017 to Monday 31 July 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Receives FDA Clearance for the O2Vent W

🕔7/12/2017 9:29:37 AM

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has received FDA 510k clearance for its O2Vent W device, an oral appliance intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnoea.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Share Purchase Plan Documents Issued to Shareholders

🕔6/27/2017 10:02:34 AM

Oventus Medical Ltd (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. The record date to be registered as a shareholder for participation in the SPP is Wednesday, 21 June 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Successful Capital Raising

🕔6/22/2017 10:07:35 AM

Oventus Medical Limited (ASX:OVN) announces that it has completed a first tranche placement of approximately 18 million shares to institutional and sophisticated investors at an issue price of $0.36 per share to raise approximately $6.5 million.

Read Full Article

Oventus Medical Ltd (ASX:OVN) World-wide Distribution Agreement with Modern Dental Group (HKG:3600)

🕔6/20/2017 8:32:10 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce it has entered into a world-wide distribution agreement with Hong Kong based Modern Dental Group (HKG:3600). This is in addition to the recent announcement of the co-manufacturing agreement between Oventus and Modern Dental.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Positive Clinical Data Presented at US Dental Sleep Meeting

🕔6/7/2017 9:24:56 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce that low pressure CPAP without a mask is one step closer. Results from the initial pilot study generated significant interest when presented at the American Academy of Dental Sleep Medicine in Boston on June 2nd 2017. The conference is the premier world forum for the latest developments in dental sleep medicine.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Maskless C-PAP One Step Closer

🕔6/2/2017 11:04:23 AM

Oventus Medical Ltd (ASX:OVN) are pleased to announce that C-PAP (Continuous Positive Airway Pressure) without a mask is one step closer signalling the first major change in sleep medicine in decades. The first patient has been recruited in the next stage of a trial combining an oral appliance and C-PAP.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Signs Manufacturing Agreement with Modern Dental

🕔5/30/2017 9:04:46 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce it has entered into a manufacturing agreement with Hong Kong based Modern Dental Group. Modern Dental have extensive expertise in the manufacture of dental appliances and hold the required quality management certifications for medical device manufacture.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Treatment Addresses Snorers at Higher Risk of Traffic Accidents

🕔5/29/2017 12:25:26 PM

The daily commute from Geelong to Melbourne just got a little more perilous with a new study warning one fifth of Australian adults have fallen asleep while driving. Research from the Sleep Health Foundation also shows nearly a third of Australians drive while drowsy at least once a month. They're figures Geelong dentist Dr Joseph Juric said are only scratching the surface.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Advances in Combatting Sleep Apnoea

🕔5/11/2017 2:01:36 PM

Treatment for sleep apnoea usually involves either a mask or a mouthguard. A new Australian invention combines the best elements of both. Brisbane dentist Chris Hart spent years struggling to sleep. He snored constantly. He often woke up during the night because he had stopped breathing because of a n obstruction in his nose and throat.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Innovators in Sleep Apnoea Treatment

🕔5/11/2017 10:30:12 AM

Oventus Medical Ltd (ASX:OVN) is pleased to provide the Company's latest Investor Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) FDA Submission Lodged for O2Vent W

🕔5/5/2017 8:33:39 AM

Australian medical device company Oventus Medical Ltd. (ASX:OVN), has lodged an FDA 510k submission for its O2Vent W device - an oral appliance intended to reduce or alleviate snoring, mild to moderate obstructive sleep apnoea and severe sleep apnoea when the patient is intolerant to Continuous Positive Airway Pressure Devices.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Clinical Evidence Update

🕔5/3/2017 1:28:58 PM

Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant progress has been made regarding the clinical validation of the Oventus O2Vent oral appliances and, in particular, validation of the benefit of the Oventus proprietary airway.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Clinical Update on Advancing PAP Connection of O2Vent

🕔5/1/2017 12:01:11 PM

Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant clinical progress made with the Oventus O2Vent oral appliance with a Positive Airway connection.

Read Full Article

Oventus Medical Ltd (ASX:OVN) - is This What the Future of Treating Sleep Apnea Looks Like?

🕔4/10/2017 9:43:44 AM

Oventus Medical Ltd (ASX:OVN) will unveil latest advancements in the field, which are changing the way the disease is treated, in San Francisco next week (April 20th). Dr Chris Hart will join more than 30 international speakers at 3DHEALS2017 - the first collaborative conference in the U.S. aiming to create a global healthcare community focusing on 3D printing and related technologies.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Update: Achieves Significant Milestones in Last Quarter and Expands Commercialisation of O2Vent T

🕔4/4/2017 3:45:08 PM

Oventus Medical Ltd (ASX:OVN) are pleased to provide the Company's latest Investor Update. Oventus have achieved a number of significant milestones in the last quarter, expanding the commercialisation efforts of our O2Vent(TM) T device in numerous geographical regions and strengthening our sales and operational systems.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Review of Operations and Expected Future Developments

🕔3/2/2017 2:43:35 PM

During the half-year the principal activities of Oventus Medical Ltd (ASX:OVN) (the Company) consisted of the commercialisation and distribution of the O2Vent(TM) T, in Australia, as well as development of a pipeline or products to treat segments of the snoring and sleep and apnoea market.

Read Full Article

Oventus Medical Ltd (ASX:OVN) $2.95 Million Grant Successful in Latest CRC-P Funding Round

🕔2/8/2017 1:54:55 PM

Oventus Medical Limited (ASX:OVN) today announced that it is the lead participant in a successful application for a grant in the 2nd round of the CRC-P grants that from the Australian Federal Government. The project will receive $2,950,000 over three years for a project titled, "Targeted therapy for sleep apnoea: A novel personalised approach".

Read Full Article

News

Oventus Medical Ltd (ASX:OVN) O2Vent Optima Launch in Canada

🕔2/4/2019 10:59:31 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent(R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea and snoring. The device launch in Canada follows the successful completion of a controlled market release, with early results demonstrating strong patient acceptance.

Read Full Article

Oventus Medical Ltd (ASX:OVN) New Nylon O2Vent Optima Oral Device Launched in Australia

🕔1/8/2019 10:36:18 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the launch of the O2Vent(R) Optima device in Australia, an important addition to the Company's sleep treatment platform.

Read Full Article

Oventus Medical Ltd (ASX:OVN) 2018 AGM Presentation

🕔11/16/2018 12:12:19 PM

Oventus Medical Ltd (ASX:OVN) provides the Company's 2018 AGM Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) New Clinical Trial Data Demonstrates Sleep Treatment Platform Delivers Significantly Improved Treatment Outcomes for OSA Sufferers

🕔10/18/2018 10:24:42 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce that new clinical data from four separate studies on its Sleep Treatment Platform will be presented at Sleep DownUnder, the 30th annual meeting of sleep specialists, taking place in Brisbane between 17th -20th October.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Appoints Medical Technology Advisory Board to Guide Commercialisation of Sleep Treatment Platform

🕔9/5/2018 4:40:07 PM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the appointment of a Medical Technology Advisory Board of international sleep experts to help guide the development and commercialisation of the Company's Sleep Treatment Platform.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Quarterly Business Review - Q4 FY2018

🕔7/24/2018 8:42:47 AM

Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 30 June 2018 (Q4 FY2018) and is pleased to provide a review of progress made during the quarter.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Investor Newsletter

🕔6/20/2018 10:17:57 AM

Oventus Medical Ltd (ASX:OVN) is pleased to provide a copy of its latest newsletter for investors.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Innovators in Sleep Apnoea Treatment Presentation for Thorney Investment Forum

🕔5/31/2018 11:29:38 AM

Oventus Medical Ltd (ASX:OVN) is pleased to attach a copy of the presentation that Founder and Clinical Director, Dr Chris Hart will deliver to investors this morning at the Thorney Sydney Investment Forum.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Data Shows O2Vent with New Valve Treats 75% of Patients

🕔5/29/2018 2:09:34 PM

Oventus Medical Ltd (ASX:OVN) is pleased to announce positive interim data being presented today in a lecture at Macquarie University on a group of hard-to-treat obstructive sleep apnoea patients, who were studied in a sub-group as part of the ongoing "NeuRA Sydney study".

Read Full Article

Oventus Medical Ltd (ASX:OVN) Airway Technology Achieves Positive Clinical Trial

🕔5/22/2018 10:21:38 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the results of the OVEN-003 clinical trial study being conducted in Brisbane by the company, a randomised controlled clinical trial examining the treatment outcomes of oral appliance therapy with and without 'Oventus Airway Technology'.

Read Full Article
###

18,898 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 64) (Last 30 Days: 365) (Since Published: 18898) 

Markets ASX:OVN

Company Data

    Headquarters
  • 1 Swann Road
    Indooroopilly
    PO Box 190, Indooroopilly
    4068 QLD Australia
  • Telephone
  • 1300 533 159 
  • Principal Sector
  • Chemical Equipment & Manufacturing 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.oventus.com.au

Company Reports

Presentations

Quarterly Report

Social Media